AI for Drug Discovery: The Future of Pharmaceuticals Industry


Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity.

REQUEST BROCHURE WITHCOMPREHENSIVE INSIGHTS



Some of the Leading Key Players Influencing this Study Include, Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics, Cloud Pharmaceuticals, Inc., BenevolentAI, twoXAR, Incorporated, Exscientia among the others.


The market payers from AI for drug discovery market are anticipated to lucrative growth opportunities in the future with the rising demand for AI for drug discovery in the global market. Below mentioned is the list of few companies engaged in the AI for drug discovery market.

The report analyzes factors affecting AI for drug discovery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the AI for drug discovery market in these regions.

The report also includes the profiles of key AI for drug discovery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

DOWNLOAD SAMPLE PDF



The reports cover key developments in the AI for drug discovery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players.

Comments

Post a Comment

Popular posts from this blog

Human Microbiome: A Vision For the Future of Biotechnology Research

Image
The Human Microbiome Project of the National Institutes of Health in the United States and related international efforts are defining the varieties of a normal microbiome, studying how changes in the microbiota relate to disease. Large governmental research initiatives including the Human Microbiome Project in the U.S. have accelerated research on the human microbiome. START FREE TRIAL Also, many companies are designing and developing many microbiome therapies. For instance, Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform which is the drug platform for delivering healthy, live, human-derived microbes into a sick patient’s intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years. Companies Mentioned • Enterome • MicroBiome Therapeutics, LLC • Rebiotix Inc. • Yakult Honsha Co., Ltd. • Osel Inc. • Vedanta Bioscienc...
Read more

Future of Umbilical Cord Blood Banking

Image
Umbilical cord blood banking is the practice of preserving blood from the umbilical cord for later use. These preserved umbilical cord blood is used in medical therapy with a similar approach to stem cells derived from bone marrow. Umbilical cord blood is collected from the newborn's umbilical cord and recovered from the placenta after delivery. It is rich in adult stem cells, and these stem cells play an important role in regulating all biological activities and developing the tissues of the human body. DOWNLOAD SAMPLE PDF Top 10 Companies Working in this Study: 1. CBR Systems, Inc.  2. Cordlife.  3. LifeCell  4. StemCyte India Therapeutics Pvt. Ltd.  5. Vita 34  6. Americord Registry LLC.  7. ESPERITE N.V  8. Global Cord Blood Corporation.  9. SMART CELLS PLUS.  10. Cord Blood America, Inc. This report provides a detailed overview of the industry, including qualitative and quantitative information. It provides an over...
Read more

Introduction of Human Health associated with Corporate Wellness Programs

Image
Corporate wellness programs are designed to encourage and support a approach to employee wellbeing by creating an organizational culture of health. Corporate Wellness becoming ever more important for consumers, fitness has become a more relevant goal for many people. It's easy to see why many Americans are overweight and different, as all our working hours depend on our cultural reliance on electronics for entertainment. In fact, according to the U.S. Department of Health and Human Services, nearly 60% of employees say they don't exercise properly. Download Sample PDF Copy Here As a result, work corporate wellness program are more important than ever. So what exactly is workplace health and how does it benefit your company? Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. - Wellness Corporate Solutions, LLC - Well Nation - Virgin Pulse - Compsych Cor...
Read more